Back to Search
Start Over
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
- Source :
-
Haematologica [Haematologica] 2016 Oct; Vol. 101 (10), pp. e407-e410. Date of Electronic Publication: 2016 Jul 14. - Publication Year :
- 2016
- Subjects :
- Adult
Aged
Aged, 80 and over
Europe epidemiology
Female
Humans
Infusions, Intravenous
Lymphoma, T-Cell, Peripheral diagnosis
Lymphoma, T-Cell, Peripheral mortality
Male
Middle Aged
Neoplasm Recurrence, Local diagnosis
Neoplasm Recurrence, Local mortality
Survival Rate trends
Young Adult
Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal, Humanized administration & dosage
Antineoplastic Agents administration & dosage
Lymphoma, T-Cell, Peripheral drug therapy
Neoplasm Recurrence, Local drug therapy
Receptors, CCR4 antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 101
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 27418646
- Full Text :
- https://doi.org/10.3324/haematol.2016.146977